Walgreens Boots Alliance Inc (WBA) Shares Bought by Achmea Investment Management B.V.
Achmea Investment Management B.V. increased its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 22.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,907 shares of the pharmacy operator’s stock after acquiring an additional 9,213 shares during the quarter. Achmea Investment Management B.V.’s holdings in Walgreens Boots Alliance were worth $3,985,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also made changes to their positions in WBA. Franklin Resources Inc. increased its holdings in shares of Walgreens Boots Alliance by 24.7% during the second quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock valued at $1,448,939,000 after acquiring an additional 3,662,302 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of Walgreens Boots Alliance by 471.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock valued at $258,077,000 after acquiring an additional 2,718,800 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Walgreens Boots Alliance by 2.8% during the second quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after buying an additional 1,926,108 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of Walgreens Boots Alliance by 5.9% during the first quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after buying an additional 1,824,300 shares during the last quarter. Finally, Glenview Capital Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the second quarter valued at $136,875,000. 60.24% of the stock is owned by institutional investors.
Several equities research analysts recently commented on WBA shares. UBS reaffirmed a “buy” rating and set a $96.00 price objective (down from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. Loop Capital assumed coverage on Walgreens Boots Alliance in a research report on Thursday, August 24th. They issued a “buy” rating and a $95.00 target price on the stock. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Jefferies Group reissued a “buy” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research report on Thursday, September 7th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research report on Sunday, September 10th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the company. Walgreens Boots Alliance has an average rating of “Buy” and a consensus price target of $86.47.
Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $70.18 on Wednesday. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00. The stock has a market capitalization of $70,879.76, a P/E ratio of 14.03, a price-to-earnings-growth ratio of 1.27 and a beta of 1.22.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. During the same quarter in the previous year, the company posted $1.07 EPS. The company’s revenue was up 5.3% compared to the same quarter last year. sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.55 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend is Friday, November 10th. Walgreens Boots Alliance’s payout ratio is 42.33%.
Walgreens Boots Alliance declared that its board has authorized a stock buyback plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback plans are often an indication that the company’s board believes its stock is undervalued.
In related news, Director John Anthony Lederer bought 20,000 shares of the business’s stock in a transaction dated Thursday, October 26th. The shares were purchased at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the transaction, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Insiders own 14.80% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.